Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Human Genetics|April 13, 2002
Impaired interactions between mouse Eyal harboring mutations found in patients with branchio-oto-renal syndrome and Six, Dach, and G proteinsHidenori Ozaki, Yoko Watanabe, Keiko Ikeda, et al.Clinical & Experimental Metastasis|January 10, 2012
Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse modelHidenori Ozaki, Hideki Matsuzaki, Hidenobu Ando, et al.Human Molecular Genetics|April 30, 2002
Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy type 1Shigeru Sato, Miwa Nakamura, Diane H Cho, et al.Clinical Chemistry|November 5, 2010
Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarrayAtsushi Kuno, Yuzuru Ikehara, Yasuhito Tanaka, et al.Journal of Muscle Research and Cell Motility|December 26, 2002
Six and Eya expression during human somitogenesis and MyoD gene family activationFrançoise Fougerousse, Muriel Durand, Soledad Lopez, et al.Cancer Research|February 5, 2008
CD43, but not P-selectin glycoprotein ligand-1, functions as an E-selectin counter-receptor in human pre-B-cell leukemia NALL-1Chizu Nonomura, Jiro Kikuchi, Nobutaka Kiyokawa, et al.Journal of Proteome Research|January 31, 2009
Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling toolsHiromi Ito, Atsushi Kuno, Hiromichi Sawaki, et al.Development (Cambridge, England)|December 26, 2003
Six1 controls patterning of the mouse otic vesicleHidenori Ozaki, Kazuaki Nakamura, Jun-ichi Funahashi, et al.Journal of Proteome Research|April 17, 2013
Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinomaHiroyuki Kaji, Makoto Ocho, Akira Togayachi, et al.Pageof 1